Medgend Icon

Ledgend of Medicine







discontinued


Exubera FDA Approved Drugs

AFREZZA [Insulin Recombinant Human]
RX
-
12 units/inh (inhalation powder)
4 units/inh (inhalation powder)
8 units/inh (inhalation powder)
MannkindApr 17, 2015
  • Administration of a composition comprising insulin complexed with a diketopiperazine..
  • Administration of a composition comprising insulin complexed with microparticles of a diketopiperazine..
  • Administration of fdkp microparticles comprising insulin..
  • Method of aerosolizing/deagglomerating an insulin dry powder for use in treating diabetes mellitus via oral inhalation using an inhaler with a cartridge containing the insulin dry powder..
  • Method of controlling glycemia in diabetics by administering an initial dose of insulin-fdkp with a meal; determining blood glucose level 1-2 hrs after and administering a supplemental dose of insulin-fdkp if postprandial glucose level is >140 mg/dl.
  • Method of delivering to a patient with diabetes mellitus in a single inhalation, greater than 75% of a dry powder dose comprising insulin and fumaryl diketopiperazine using a high resistance to flow dry powder inhaler..
  • Pulmonary administration of a compisition comprising insulin bound to a diketopiperazine..
  • Pulmonary administration of a composition comprising insulin bound to a complexing agent..
  • Pulmonary administration of an insulin composition comprising fdkp at the beginning of a meal to a patient also being treated with a long-acting insulin..
  • Treatment of a patient having diabetes mellitus with a prandial rapid acting insulin..
  • Treatment of diabetes mellitus with an inhaled insulin to improve glycemic control using a dry powder inhalation system comprising an inhaler, a cartridge and a dry powder medicament comprising insulin in a single inhalation.
  • Treatment of patient having diabetes mellitus via oral inhalation of fdkp microparticles comprising insulin.
  • Use of an inhaler to administer dry powder medicament.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

HUMULIN R [Insulin Recombinant Human]
OTC
-
100 units/ml (injection injectable)
LillyOct 28, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

HUMULIN R PEN [Insulin Recombinant Human]
OTC
-
100 units/ml (injection injectable)
LillyAug 6, 1998
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

NOVOLIN R [Insulin Recombinant Human]
OTC
-
100 units/ml (injection injectable)
Novo Nordisk IncJun 25, 1991
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.


WARNING: All medicines, drugs, plants, chemicals or medicial precedures below are for historical reference only. Many of these treatments are now known to be harmful and possibly fatal. Do not consume any plant, chemical, drug or otherwise without first consulting a licensed physician that practices medine in the appropriate field.

Physician's Materia Medica on Exubera

ACID ACETIC
   Glacial Acetic Acid is caustic; used accordingly to destroy warts or exuberant granulations. The diluted acid is used to arrest hemor rhages and as a lotion to prevent night sweats. The official prepa-- rations are; Glacial Acetic Acid, containing about 99 per cent.; Acetic. Acid, 36 per cent., and Dilnted Acetic Acid, 6 per cent. of ab solute acid.1


References

1) Nelson, Baker & Co., 1904, Physician's Handy Book of Materia Medica and Therapeustics, Detroit, Michigan.